Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keda Yu

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2020
Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III TrialJunjie Li, Keda Yu, Da Pang, et al.
Holistic Integrative Oncology|July 31, 2023
CACA Guidelines for Holistic Integrative Management of Breast CancerJiong Wu, Daiming Fan, Zhimin Shao, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2020
Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III TrialJunjie Li, Keda Yu, Da Pang, et al.
Holistic Integrative Oncology|July 31, 2023
CACA Guidelines for Holistic Integrative Management of Breast CancerJiong Wu, Daiming Fan, Zhimin Shao, et al.
Pageof 5